HPLC-accelerator MS measurement of atrazine metabolites in human urine after dermal exposure.
about
Mixed-effect models for evaluating multiple measures of atrazine exposure among custom applicatorsBiomonitoring of exposure in farmworker studiesAtrazine and breast cancer: a framework assessment of the toxicological and epidemiological evidenceFree flow electrophoresis separation and AMS quantitation of C-naphthalene-protein adductsUse of Accelerator Mass Spectrometry in Human Health and Molecular ToxicologyMass spectrometry-based metabolomics.Accelerator mass spectrometry-enabled studies: current status and future prospects.The ethics of human volunteer studies involving experimental exposure to pesticides: unanswered dilemmasQuantifying exploratory low dose compounds in humans with AMS.Isotope-labeled immunoassays without radiation wasteAttomole level protein sequencing by Edman degradation coupled with accelerator mass spectrometry.Assessing exposure to atrazine and its metabolites using biomonitoringPresence of atrazine in the biological samples of cattle and its consequence adversity in human health.Quantum Dots as Reporters in Multiplexed Immunoassays for Biomarkers of Exposure to Agrochemicals.Recent advances in biomedical applications of accelerator mass spectrometry.From definition to implementation: a cross-industry perspective of past, current and future MIST strategies.Atrazine exposure affects longevity, development time and body size in Drosophila melanogaster.Use of accelerator mass spectrometry for studies in nutrition.Oxidative stress induced by atrazine in rat erythrocytes: mitigating effect of vitamin E.Investigation of atrazine metabolism in river sediment by high-performance liquid chromatography/mass spectrometry.Changes in hepatic phase I and phase II biotransformation enzyme expression and glutathione levels following atrazine exposure in female rats.
P2860
Q23911339-8E04F136-A1D1-45C9-B47C-155FBF336588Q23911554-3E1129A9-6B1F-4E33-B64F-0D17EC998876Q28392184-5C12B0E3-8D0E-45A6-B1B3-35A8AE8DF8D9Q28752369-8CDC8EA5-FC85-4EB2-B6D5-F712617049EEQ28818313-4CB6CD84-1AD3-4CF2-9F64-FFCD7F0D62FFQ33254576-AB4C19E4-752A-446B-9021-A103744EE7C0Q33819361-46C39455-2558-4ECC-BB17-4EF00F42D0D8Q34097909-B7A03329-51AF-4783-9539-1939735836E7Q34708648-E16D9C97-7849-4C07-A48D-F09B54D5807FQ35073607-1DA9DEFA-A87B-4991-9E3C-74A6933F073AQ35252821-0837D3E3-ECCF-46AE-823B-028F727C6216Q36065025-CB64B02E-B7C9-4A02-B9FB-0F1239C4C53BQ36349088-2A760467-6B37-40AD-BA2A-54321C7B227EQ37010059-2BDA3219-D7E8-4108-A788-AEC7F9C3A2A1Q37266360-4784151F-C081-4321-8CBF-807947604BA2Q37859007-B14CF168-5264-432A-A1F7-D9150907A76DQ38851449-18DC71E5-363C-4742-9AF8-435B28FA31C5Q40674194-36D1505C-5F2B-4771-A2C1-4E27F3CF37DEQ43171713-9F322990-CAB7-488C-A9DE-C7FBA752D69BQ43736648-DB157B2B-E402-4217-AD3D-07241586AD49Q47647986-6D759A67-C4EE-4359-91EA-469923A2C3F4
P2860
HPLC-accelerator MS measurement of atrazine metabolites in human urine after dermal exposure.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
HPLC-accelerator MS measuremen ...... n urine after dermal exposure.
@en
type
label
HPLC-accelerator MS measuremen ...... n urine after dermal exposure.
@en
prefLabel
HPLC-accelerator MS measuremen ...... n urine after dermal exposure.
@en
P2093
P356
P1433
P1476
HPLC-accelerator MS measuremen ...... an urine after dermal exposure
@en
P2093
B D Hammock
H I Maibach
R C Wester
P304
P356
10.1021/AC990152G
P407
P577
1999-08-01T00:00:00Z